Abstract

T cell vaccines against Mycobacterium tuberculosis (Mtb) and other pathogens are based on the principle that memory T cells rapidly generate effector responses upon challenge, leading to pathogen clearance. Despite eliciting a robust memory CD8+ T cell response to the immunodominant Mtb antigen TB10.4 (EsxH), we find the increased frequency of TB10.4-specific CD8+ T cells conferred by vaccination to be short-lived after Mtb challenge. To compare memory and naïve CD8+ T cell function during their response to Mtb, we track their expansions using TB10.4-specific retrogenic CD8+ T cells. We find that the primary (naïve) response outnumbers the secondary (memory) response during Mtb challenge, an effect moderated by increased TCR affinity. To determine whether the expansion of polyclonal memory T cells is restrained following Mtb challenge, we used TCRβ deep sequencing to track TB10.4-specific CD8+ T cells after vaccination and subsequent challenge in intact mice. Successful memory T cells, defined by their clonal expansion after Mtb challenge, express similar CDR3β sequences suggesting TCR selection by antigen. Thus, both TCR-dependent and -independent factors affect the fitness of memory CD8+ responses. The impaired expansion of the majority of memory T cell clonotypes may explain why some TB vaccines have not provided better protection.

Highlights

  • The goal of T cell vaccination is to establish pre-existing immunity against pathogens in the form of memory T cells

  • CD8+ T cells are important for enforcing latency of tuberculosis, and for Mycobacterium tuberculosis (Mtb) control in patients with HIV and low CD4 counts

  • We have some understanding of the fate of memory T cell responses against pathogens that cause chronic infections, such as LCMV clone-13, a model pathogen that causes chronic infection in mice [6,7], little is known about the relative contribution of naïve and memory T cells to the recall response elicited by the human pathogen Mycobacterium tuberculosis (Mtb)

Read more

Summary

Introduction

The goal of T cell vaccination is to establish pre-existing immunity against pathogens in the form of memory T cells. Two features of memory T cells make them superior to naïve T cells in mediating protection. Memory T cells have undergone a cycle of expansion and contraction, leading to a greater frequency of pathogen-specific T cells than present among the naïve T cell repertoire. We have some understanding of the fate of memory T cell responses against pathogens that cause chronic infections, such as LCMV clone-13, a model pathogen that causes chronic infection in mice [6,7], little is known about the relative contribution of naïve and memory T cells (and the resulting 1° and 2° responses, respectively) to the recall response elicited by the human pathogen Mycobacterium tuberculosis (Mtb)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call